CA 15-3 and related mucins as circulating markers in breast cancer

被引：78

作者：

Duffy, MJ ^{[1
]}

机构：

[1] St Vincents Hosp, Dept Nucl Med, Dublin 4, Ireland

来源：

ANNALS OF CLINICAL BIOCHEMISTRY | 1999年 / 36卷

关键词：

MUC1; BR; 27.29;

D O I：

10.1177/000456329903600503

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：579 / 586

页数：8

共 51 条

[1] Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [J].

Agrawal, B ;

Krantz, MJ ;

Reddish, MA ;

Longenecker, BM .

NATURE MEDICINE, 1998, 4 (01) :43-49

[2]

[Anonymous], P AM SOC CLIN ONCOL

[3] CARCINOEMBRYONIC ANTIGEN IN STAGING AND FOLLOW-UP OF PATIENTS WITH SOLID TUMORS [J].

BALLESTA, AM ;

MOLINA, R ;

FILELLA, X ;

JO, J ;

GIMENEZ, N .

TUMOR BIOLOGY, 1995, 16 (01) :32-41

[4]

Bast RC, 1996, J CLIN ONCOL, V14, P2843

[5] PROGNOSTIC VALUE IN PREDICTING OVERALL SURVIVAL OF 2 MUCINOUS MARKERS - CA-15-3 AND CA-125 IN BREAST-CANCER PATIENTS AT FIRST RELAPSE OF DISEASE [J].

BERRUTI, A ;

TAMPELLINI, M ;

TORTA, M ;

BUNIVA, T ;

GORZEGNO, G ;

DOGLIOTTI, L .

EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) :2082-2084

[6]

Bon GG, 1997, CLIN CHEM, V43, P585

[7] Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values [J].

Bon, GG ;

Kenemans, P ;

Verstraeten, R ;

vanKamp, GJ ;

Hilgers, J .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) :107-114

[8]

BRAY KR, 1987, CANCER RES, V47, P5853

[9] Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease [J].

Chan, DW ;

Beveridge, RA ;

Muss, H ;

Fritsche, HA ;

Hortobagyi, G ;

Theriault, R ;

Kiang, D ;

Kennedy, BJ ;

Evelegh, M .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2322-2328

[10]

COLOMER R, 1989, CANCER, V64, P1674, DOI 10.1002/1097-0142(19891015)64:8<1674::AID-CNCR2820640820>3.0.CO

← 1 2 3 4 5 6 →